ERAS and lung carcinoma: The main clinical and pathological characteristics of the ERAS and non-ERAS groups are summarized in Table 2, showing no difference in sociodemographic or clinical variables distribution, no difference in comorbidity index, no difference in characteristics tumours by group, except for the ERAS group having a more advanced-stage lung cancer distribution.